C-type natriuretic peptide-mediated coronary vasodilation: role of the coronary nitric oxide and particulate guanylate cyclase systems

Department of Medicine, Mayo Clinic, Rochester, Minnesota 55905, USA.

OBJECTIVES: We tested the hypothesis that C-type natriuretic peptide (CNP) mediates coronary vasodilation through activation of cyclic guanosine monophosphate (cGMP) by way of particulate guanylate cyclase. BACKGROUND: CNP has known peripheral vasodilator properties, and preliminary data have suggested that it can function as a coronary vasodilator. METHODS: The actions of CNP were studied in instrumented dogs and in organ chamber rings in the presence and absence of a known antagonist to particulate guanylate cyclase, HS-142-1. Additionally, the actions of HS-142-1 were tested on acetylcholine-mediated coronary vasodilation, and immunohistochemical staining was utilized to localize the presence of CNP in the coronary endothelium. RESULTS: CNP relaxed isolated coronary arteries with (mean +/- SEM 45.9 +/- 7%*) and without (72.0 +/- 7%*) an endothelium (*p < 0.05 for CNP effect alone, p < 0.05 for endothelium vs. no endothelium with CNP). Intracoronary infusions increased coronary blood flow (baseline, 64.6 +/- 5.1 ml/min; CNP-5, 79.9 +/- 6.1*; CNP-20, 103.3 +/- 13.6* [*p < 0.05 vs. baseline value]) and reduced coronary vascular resistance (baseline, 1.6 +/- 0.3 mm Hg/ml per min; CNP-5, 1.4 +/- 0.3*; CNP-20, 1.2 +/- 0.3*). Intracoronary injections increased coronary blood flow (delta baseline coronary flow, 30 +/- 9* ml/min [*p < 0.05]). HS-142-1 significantly attenuated these increases (delta coronary flow, 30 +/- 9* ml/min [CNP] to 14 +/- 6 [CNP + HS-142-1] [p < 0.05 CNP vs. CNP + HS-142-1]) and the relaxation of organ chamber rings (56 +/- 7% [CNP] to 18 +/- 6% [HS-142-1 + CNP]). Finally, CNP was localized to the coronary endothelium and smooth muscle by immunohistochemical staining. CONCLUSIONS: CNP functions as a coronary vasodilator through activation of cGMP by way of particulate guanylate cyclase. CNP-mediated coronary vasodilation is attenuated by intracoronary HS-142-1. Intracoronary HS-142-1 does not affect acetylcholine-mediated coronary vasodilation. These observations support a role for exogenous CNP as a potent coronary vasodilator.

This article has been cited by other articles:

				C. F. Liang, A. L. S. Au, S. W. S. Leung, K. F. J. Ng, M. Feletou, Y. W. Kwan, R. Y. K. Man, and P. M. Vanhoutte Endothelium-Derived Nitric Oxide Inhibits the Relaxation of the Porcine Coronary Artery to Natriuretic Peptides by Desensitizing Big Conductance Calcium-Activated Potassium Channels of Vascular Smooth Muscle J. Pharmacol. Exp. Ther., July 1, 2010; 334(1): 223 - 231. [Abstract] [Full Text] [PDF]

				A. Hobbs, P. Foster, C. Prescott, R. Scotland, and A. Ahluwalia Natriuretic Peptide Receptor-C Regulates Coronary Blood Flow and Prevents Myocardial Ischemia/Reperfusion Injury: Novel Cardioprotective Role for Endothelium-Derived C-Type Natriuretic Peptide Circulation, September 7, 2004; 110(10): 1231 - 1235. [Abstract] [Full Text] [PDF]

				S. Lakshminrusimha, C. A. D'Angelis, J. A. Russell, L. C. Nielsen, S. F. Gugino, P. A. Nickerson, and R. H. Steinhorn C-type natriuretic peptide system in fetal ovine pulmonary vasculature Am J Physiol Lung Cell Mol Physiol, August 1, 2001; 281(2): L361 - L368. [Abstract] [Full Text] [PDF]

				H. D. Intengan and E. L. Schiffrin Vasopeptidase Inhibition Has Potent Effects on Blood Pressure and Resistance Arteries in Stroke-Prone Spontaneously Hypertensive Rats Hypertension, June 1, 2000; 35(6): 1221 - 1225. [Abstract] [Full Text] [PDF]

				M. Hirose, Y. Furukawa, Y. Miyashita, F. Kurogouchi, K. Nakajima, M. Tsuboi, and S. Chiba CNP causes receptor-mediated positive dromotropic effects in anesthetized dog hearts Am J Physiol Heart Circ Physiol, August 1, 1998; 275(2): H717 - H720. [Abstract] [Full Text] [PDF]

				H. Itoh, I. M. Bird, K. Nakao, and R. R. Magness Pregnancy Increases Soluble and Particulate Guanylate Cyclases and Decreases the Clearance Receptor of Natriuretic Peptides in Ovine Uterine, But Not Systemic, Arteries Endocrinology, July 1, 1998; 139(7): 3329 - 3341. [Abstract] [Full Text] [PDF]

				Y.-P. Fan, S. Chakder, and S. Rattan Inhibitory Effect of Zinc Protoporphyrin IX on Lower Esophageal Sphincter Smooth Muscle Relaxation by Vasoactive Intestinal Polypeptide and Other Receptor Agonists J. Pharmacol. Exp. Ther., May 1, 1998; 285(2): 468 - 474. [Abstract] [Full Text]

				G. Barletta, C. Lazzeri, S. Vecchiarino, R. Del Bene, G. Messeri, A. Dello Sbarba, M. Mannelli, and G. La Villa Low-Dose C-Type Natriuretic Peptide Does Not Affect Cardiac and Renal Function in Humans Hypertension, March 1, 1998; 31(3): 802 - 808. [Abstract] [Full Text] [PDF]